Dissertations / Theses on the topic 'Bifidobacterium'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Bifidobacterium.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Васильєва, К. О., and І. М. Волошина. "Біотехнологічні аспекти Bifidobacterium." Thesis, Київський національний університет технологій та дизайну, 2020. https://er.knutd.edu.ua/handle/123456789/15599.
Full textBahaka, Driss. "Analyse phenotypique et genotypique des souches du genre bifidobacterium appartenant ou apparentees aux especes b. Breve, b. Infantis et b. Longum." Lille 2, 1993. http://www.theses.fr/1993LIL2P254.
Full textGrill, Jean-Pierre. "Étude du potentiel probiotique de bactéries du genre Bifidobacterium : purification et caractérisation de la fructose 6 phosphate phosphocetolase de Bifidobacterium longum et Bifidobacterium animalis." Nancy 1, 1995. http://www.theses.fr/1995NAN10050.
Full textOberg, Taylor S. "Characterization of the Hydrogen Peroxide Stress Responses of Bifidobacterium longum and Bifidobacterium animalis subsp. Lactis." DigitalCommons@USU, 2013. https://digitalcommons.usu.edu/etd/2037.
Full textNunoura, Naoki. "Studies on Bifidobacterium breve β-Glucosidase." Kyoto University, 1997. http://hdl.handle.net/2433/202382.
Full text0048
新制・課程博士
博士(農学)
甲第6899号
農博第917号
新制||農||739(附属図書館)
学位論文||H9||N3023(農学部図書室)
16016
UT51-97-H283
京都大学大学院農学研究科食品工学専攻
(主査)教授 熊谷 英彦, 教授 木村 光, 教授 清水 昌
学位規則第4条第1項該当
Hassi, Chafiq. "Contribution a l'etude d'utilisation de la n-acetyl-beta-d-glucosamine par b. Bifidum atcc 15696 et b. Animalis atcc 25527 : preparation, purification et caracterisation de leur n-acetyl-beta-d-glucosaminidase." Lille 2, 1994. http://www.theses.fr/1994LIL2P253.
Full textMizerovská, Lucie. "Selektivní izolace bakterií rodu Bifidobacterium z potravin." Master's thesis, Vysoké učení technické v Brně. Fakulta chemická, 2012. http://www.nusl.cz/ntk/nusl-216880.
Full textOrrhage, Kerstin. "Impact of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microflora and bioavailability of some food mutagens /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3687-0/.
Full textAppourchaux, Laurence. "Purification et propriétés des béta-D-galactosidases des N-acétyl-béta-D-glucosaminidases de Bifidobacterieum bifidum souche AA 2/2." Lille 1, 1989. http://www.theses.fr/1989LIL10164.
Full textBoutry, Etienne. "Exoglycosidases de Bifidobacterium bifidum souche AA 2/2." Lille 1, 1989. http://www.theses.fr/1989LIL10163.
Full textArany, Catherine Beatrice \d 1968. "Enhanced recovery of injured and noninjured cells of Bifidobacterium species from water and dairy products /." This resource online, 1992. http://scholar.lib.vt.edu/theses/available/etd-12162009-020131/.
Full textTrindade, Marla. "Studies on carbohydrate metabolism in Bifidobacterium : isolation, characterisation and regulation of a sucrose-utilisation gene cluster in Bifidobacterium lactis." Doctoral thesis, University of Cape Town, 2002. http://hdl.handle.net/11427/4341.
Full textThe primary aim of the project was, therefore, to analyse carbohydrate metabolism for the identification of and/or the development of prebiotic substrates, and to provide a molecular characterisation for their utilisation. Several carbohydrates were tested for their ability to support the growth of bifidobacteria as a sole carbohydrate source. The four bifidobacterial strains, B. breve, B. bifidum, B. longum and B. lactis were able to utilise a wide variety of substrates.
Fachin, Luciano. "Contagem de Bifidobacterium animalis Bb 12 e efeito da adição de Propionibacterium freudenreichii PS-1 e do tratamento termico do leite sobre o desenvolvimento de Bifidobacterium animalis Bb 12 em iogurte." [s.n.], 2005. http://repositorio.unicamp.br/jspui/handle/REPOSIP/255805.
Full textTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Engenharia de Alimentos
Made available in DSpace on 2018-08-04T02:47:09Z (GMT). No. of bitstreams: 1 Fachin_Luciano_D.pdf: 623874 bytes, checksum: 39038138708fcb9d94eb3e5320272cbb (MD5) Previous issue date: 2005
Resumo: A produção de iogurtes com Bifidobacterium spp. tem crescido muito nas últimas décadas visando a produção de alimentos funcionais. Contudo, para que o produto possa apresentar tais propriedades, tem sido alegado que o número mínimo de células viáveis de Bifidobacterium spp. presentes no momento do consumo deva ser de 106 UFC/g de produto. Entretanto, vários estudos têm mostrado produtos comerciais com contagens menores do que as recomendadas, durante a estocagem do iogurte. Esse fato é reflexo tanto da dificuldade de incorporação destes microrganismos ao iogurte, devido às condições de processo que não são favoráveis ao desenvolvimento da bifidobactéria, bem como pela dificuldade de enumeração destes microrganismos na presença das culturas do iogurte. Este trabalho avaliou o uso dos meios M-MRS, MRS-NNLP, MRS-LP, RCPB pH5 e RCPB pH5 enriquecido com extrato de fígado, visando a contagem seletiva ou diferencial de Bifidobacterium animalis Bb 12 na presença das culturas do iogurte e estudou o efeito do tratamento térmico do leite, visando o aumento do teor de lactulose e, da adição de Propionibacterium freudenreichii PS-1, sobre o desenvolvimento e manutenção do número de células viáveis de B. animalis Bb 12 durante a fermentação e estocagem do iogurte. Dos meios estudados, o meio RCPB pH5, enriquecido com 150mL/L de extrato de fígado, foi o mais indicado para a contagem de B. animalis Bb 12 em iogurte por ter apresentado uma excelente diferenciação deste microrganismo, após a estocagem refrigerada do iogurte. O tratamento térmico do leite de 142°C/15 segundos não afetou o desenvolvimento de B. animalis Bb 12 durante a fermentação do iogurte e também não influenciou a sua resistência à estocagem refrigerada. Entretanto, o tratamento térmico alterou significativamente a textura, diminuindo consideravelmente a dureza, gomosidade e adesividade do iogurte, resultando em um produto com menor separação de soro. A adição de P. freudenreichii PS-1 aumentou em aproximadamente duas vezes o número de células de B. animalis Bb 12 ao final da fermentação e melhorou a resistência da bifidobactéria à estocagem refrigerada. A presença da propionibactéria também alterou significativamente a textura final do iogurte, aumentando consideravelmente a gomosidade e adesividade do produto final, bem como resultou em um iogurte com menor separação de soro durante a estocagem refrigerada
Abstract: Bifidobacterium spp. has been used to produce probiotic yoghurts due to its therapeutic properties. However, it has been claimed that the number of bifidobactéria in yoghurt at the time of consuming must be 106 CFU /g of product to perform their therapeutic functions. Many studies found a low recovery of bifidobactéria from commercial products during shelf life. The low viability of bifidobactéria can be attributed to the process conditions of yoghurt, which is not favorable to the growth of bifidobactéria, and to the difficulty for enumeration of bifidobactéria in the presence of yoghurt bacteria. The objectives of this work were to evaluate the following media: M-MRS, MRS-NNLP, MRS-LP, RCPB pH5 and fortified RCPB pH5 to enumerate B. animalis Bb 12 in yoghurt, and to evaluate the heat treatment of milk (142°C/15 seconds) and the addition of P. freudenreichii PS-1 on the growth of B. animalis Bb 12 during yoghurt fermentation and during shelf life. RCPB pH5 fortified with 150 mL/L of liver extract was the best media due to its excellent differentiation during refrigerated storage of yoghurt. The heat treatment of milk (142°C/15 seconds) did not have effect on the growth of bifidobactéria during fermentation and it also did not improve the bifidus viability during storage. Heat treatment, however, had a strong effect on yoghurt texture, decreasing the sineresis and some parameters of TPA (hardness, gumminess and adhesiveness). The addition of P. freudenreichii PS-1 increased two fold the bifidobactéria growing during yoghurt fermentation and it also increased the viability of bifidobactéria during yoghurt shelf life. The addition of P. freudenreichii PS-1 also decreased the sineresis and increased TPA parameters of hardness, gumminess and adhesiveness. Addition of P. freudenreichii PS-1 to the yoghurt seems to be a good growth promoter for B. animalis Bb 12
Doutorado
Tecnologia de Alimentos
Doutor em Tecnologia de Alimentos
Corneau, Nathalie. "Analyse moléculaire de trois plasmides de Bifidobacterium longum." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape2/PQDD_0020/MQ55844.pdf.
Full textGann, Reed N. "Host Signaling Response to Adhesion of Bifidobacterium infantis." DigitalCommons@USU, 2010. https://digitalcommons.usu.edu/etd/586.
Full textCentanni, Manuela <1984>. "Bifidobacterium - Human Host Interaction: Role of Human Plasminogen." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2012. http://amsdottorato.unibo.it/4677/1/Centanni_Manuela_tesi.pdf.
Full textCentanni, Manuela <1984>. "Bifidobacterium - Human Host Interaction: Role of Human Plasminogen." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2012. http://amsdottorato.unibo.it/4677/.
Full textOliveira, Luiz Fernando Ferreira de. "Administração tópica do probiótico Bifidobacterium animalis subsp. lactis HN019 reduz a destruição tecidual periodontal em ratos com periodontite experimental: estudo histológico, microtomográfico, imunológico e microbiológico." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/58/58132/tde-24052016-092031/.
Full textThe purpose of this study was to evaluate the effects of topical administration of probiotic bacteria of the genus Bifidobacterium on experimental periodontal disease in rats. 32 rats were divided into groups C (control), EP (experimental periodontitis), C-HN019 (control + probiotic) and EP-HN019 (EP+ probiotic). On day 0 of the experiment, periodontitis was induced in the animals of groups EP and EP-HN019 through the placement of ligatures around mandibular first molars. In groups C-HN019 and EP-HN019, 2 mL of suspensions containing 109 colony-forming units/mL of Bifidobacterium animalis subsp lactis (B. lactis) HN019 were topically administered in the subgingival region of mandibular first molars on days 0, 3 and 7 of the experiment. In groups C and EP, topical administrations were performed using a sham suspension (without probiotic). All animals were euthanized 14 days after the beginning of the experiment. Gingival tissue, hemi-mandibles and oral biofilm were collected for evaluation of the following parameters: i) bacterial microbiota (checkerboard DNA-DNA hybridization), ii) expression of pro- and anti-inflammatory cytokines (Multiplex analysis), iii) immunoreactivityof antimicrobial peptides (immunohistochemical reactions - streptavidin-biotin-peroxydase); iV) connective tissue attachment levels (histomorphometric analysis) and v) bone microarchitecture and volume (microtomographic analysis). Data were statistically analyzed (p < 0.05). Group EP presented greater values of bone porosity, trabecular separation and connective tissue attachment loss as well as reduced trabecular number and bone volume when compared with all the other groups (p < 0.05). In group EP-HN019, there were greater percentages of bacteria of the yellow and blue complexes and greater expressions of Osteoprotegerin (OPG) and beta-defensins (BD)-1, BD-2 and BD-3 when compared with group EP (p < 0.05). Group EP presented greater levels of Interleukin (IL)-1β and Receptor Activator of Nuclear Factor-Kappa B ligand (RANKL) than group EP-HN019 (p < 0.05). The increase in the ratios RANKL/OPG and IL-1β/IL-10 was greater in group EP than in group EP-HN019 (p < 0.05). Within the limits of the present study, it can be concluded that the topical use of B. lactis HN019 promotes a protective effect against alveolar bone and connective tissue attachment losses attributable to experimental periodontitis in rats.
Jayamanne, Vijith S. "Survival of probiotic Bifidobacterium spp. in fermented milk products." Thesis, University of Surrey, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.435219.
Full textLiserre, Alcina Maria. "Microencapsulação de Bifidobacterium lactis para aplicação em leites fermentados." Universidade de São Paulo, 2005. http://www.teses.usp.br/teses/disponiveis/9/9131/tde-26042016-181206/.
Full textBifidobacterium spp. are microorganisms that can be added to foods. However, the benefits for the human health occur when the numbers of viable cells in the moment of the consumption is at least 106CFU/g. Bifidobacteria are acid sensitive, and methods to protect cell integrity, such as microencapsulation, are needed. In the first part of the present study, Bifidobacterium lactis was encapsulated in microparticles of alginate and modified alginate (alginate-chitosan, alginate-chitosan-sureteric and alginate-chitosan-acryl-eze) and the survival and release from microparticles in simulated gastrointestinal conditions were measured, using buffers (pH 1.5, 5.6 and 7.5), in the absence and presence of pepsin (3g/L), pancreatin (1g/L) and bile. The release from microparticles presented a direct relationship with pH. When the pH was 1.5 and no enzyme was present, encapsulation improved the survival of B. lactis, when compared to free cells. However, pepsin had a protective effect on B. lactis, and the survival rate was directly related to the cells injury degree. In the second part of the study, fermented milk samples containing Streptococcus salivarius ssp. thermophilus and Lactobacillus delbrueckii ssp. Bulgaricus were supplemented with B. lactis submitted to four different treatments: dehydration at room temperature, freeze drying, encapsulation in alginate-chitosan and encapsulation in alginate-chitosaacryl-eze. The number of viable B. lactis cells in the fermented milk was determined weekly and also after treatment with simulated gastrointestinal conditions. Results indicated that in the absence of pepsin, the number of viable cells decreased significantly after contact with buffers (pH 1.5), and no viable cell was detected after 120 minutes. Pepsin improved the recovery of viable cells in the assayed gastric conditions, being the dehydrated cultures more resistant than other cultures. In fermented milk containing the dehydrated cells, the number of viable cells increased after treatment with simulated gastrointestinal fluids. Microencapsulation was not an effective procedure to protect B. lactis in fermented milk against injury caused by the simulated gastrointestinal tract.
Collado, Amores María Carmen. "Caracterización de cepas del género Bifidobacterium con carácter probiótico." Doctoral thesis, Universitat Politècnica de València, 2008. http://hdl.handle.net/10251/1907.
Full textCollado Amores, MC. (2005). Caracterización de cepas del género Bifidobacterium con carácter probiótico [Tesis doctoral no publicada]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/1907
Palancia
Freitas, Camila Maria de. "Efeito da administração de bactérias ácido-láticas sobre o ganho de peso de leitões na maternidade." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/10/10135/tde-02122008-154629/.
Full textThe experiment was carried in the gestation and farrowing environment of the Faculty of Veterinary Medicine and Zootechny at University of Sao Paulo, in Pirassununga, to evaluate the effect of lactic acid probiotic bacteria administration on weight gain of a specific group of piglets just after the birth and before first colostrum suckling. For a better comparison, we designed another group of piglets, placebo, which received distilled water in the same volume and manner as probiotic group. All the animals were weighed weekly since birth until weaning, occurred with 21 days old. The average daily weight gain ranges also were considered. The tested probiotic did not change efficiently the weight gain of the animals (P>0,05), however, probiotic treated animals had greater average daily weight gain counts, mainly obvious at 7 and 14 days old, being able to justify the hypothesis of the nutrients economy existence, used by the host, owner of a stable and healthy microbiota.
Carrasco, Leiva Carolina Andrea. "Diversidad de especies y genotipos de bifidobacterium en saliva y caries de niños chilenos de 7 a 11 años de edad con y sin caries." Tesis, Universidad de Chile, 2016. http://repositorio.uchile.cl/handle/2250/141803.
Full textINTRODUCCIÓN: La cavidad oral posee una microbiota residente característica, la cual, en un estado de equilibrio, coexiste en armonía con el hospedero y es beneficiosa para el mismo. Esta homeostasis bacteriana puede verse alterada al ser perturbado el hábitat, provocando un desequilibrio de la microbiota residente, lo que induce al desarrollo de patógenos oportunistas que facilitan el progreso de la caries dental, que corresponde a un proceso patológico mediado por bacterias, de origen multifactorial, altamente prevalente y costoso de tratar. Entre estos patógenos, han sido descritas ciertas especies del género Bifidobacterium, las cuales corresponden a bacterias Gram positivo, anaerobias, con propiedades acidogénicas y acidúricas, polimórficamente ramificadas, no móviles y no formadoras de esporas. A la fecha no existen estudios publicados sobre la diversidad de especies y genotipos de Bifidobacterium spp. en la cavidad oral de niños, ni de su asociación con caries. OBJETIVO: Analizar las diversidad de especies y genotipos de Bifidobacterium, en saliva y caries dentinaria de niños chilenos de 7 a 11 años de edad con caries y en saliva de niños libres de caries. MATERIAL Y MÉTODOS: Protocolo aprobado por el Comité de Ética de la Facultad de Odontología. Previo consentimiento de los padres, se tomaron muestras de saliva y caries a niños Chilenos de 7-11 años (9 sin caries y 9 con caries), en la Clínica Odontológica, Universidad de Chile. Las muestras fueron sembradas en el medio de cultivo Triptona - Fitona - Extracto de Levadura modificado (MTPY), selectivo para Bifidobacteriaceae, e incubadas 72 hrs a 37°C en anaerobiosis. De las colonias crecidas, se seleccionaron 16 al azar desde cada muestra, para aislamiento de ADN. A través de la realización de reacción en cadena de la polimerasa (PCR) con oligonucleótidos específicos para Bifidobacteriaceae y oligonucleótidos específicos para amplificación de un fragmento de ADN del gen de 16S rRNA bacteriano, en los casos que no amplificaron con oligonucleótidos específicos para Bifidobacteriaceae. El producto de PCR fue purificado y posteriormente se secuenciaron e identificaron las especies. Finalmente se diferenciaron los genotipos de las especies pertenecientes a la familia Bifidobacteriaceae, mediante PCR basado en secuencias repetitivas (REP-PCR) y se realizaron análisis estadísticos de los resultados. RESULTADOS: No se detectaron Bifidobacterium spp. en la cavidad oral de los sujetos de estudio, sin embargo se aislaron otras especies a partir del medio de cultivo MTPY. Actinomyces odontolyticus fue asociado a la saliva de los niños, independiente de su experiencia de caries. Rothia mucilaginosa se vio asociada a la cavidad oral de los sujetos libres de caries. Lactobacillus spp. se vio asociado a la cavidad oral de sujetos con experiencia de caries. Parascardovia denticolens estuvo fuertemente asociada a sitios de caries. CONCLUSIONES: No se logró validar ni refutar la hipótesis de trabajo del presente estudio, debido a que no fue posible aislar Bifidobacterium spp, desde las muestras de los sujetos participantes. Se encontró asociación entre algunas de las especies aisladas en este estudio, con la experiencia de caries de los sujetos y el tipo de muestra. Los aislados de Parascardovia denticolens presentaron una amplia variedad de genotipos, pero con un mismo origen filogenético.
Adscrito a Proyecto U-inicia Difarp 40/13, VID, U. de Chile
Stievenard, Sylvain. "Hydrolyse industrielle du lactose : mise au point au stade laboratoire d'un réacteur à lactase immobilisée." Lille 1, 1986. http://www.theses.fr/1986LIL10172.
Full textMangin, Irène. "Typage moléculaire de souches du genre bifidobacterium : polymorphisme génétique intraspécifique et intragénérique." Nancy 1, 1994. http://docnum.univ-lorraine.fr/public/SCD_T_1994_0123_MANGIN.pdf.
Full textBravo, Caba Marta Fernanda. "Presencia de factores de virulencia en miembros de la familia Bifidobacteriaceae aisladas desde cavidad oral de niños chilenos de 7 a 11 años." Tesis, Universidad de Chile, 2016. http://repositorio.uchile.cl/handle/2250/141599.
Full textINTRODUCCIÓN: La caries dental es una enfermedad crónica compleja y multifactorial, de componente infeccioso y de alta prevalencia en el ser humano. Se desarrolla producto de la interacción en el tiempo de una producción de ácidos a partir del metabolismo bacteriano, los dientes y la saliva. La microbiota que interactúa en este proceso es muy diversa. Estudios recientes han identificado a miembros de la familia Bifidobacteriaceae como microorganismos participantes de este proceso. Estos estudios son, en su mayoría, en adultos, y no existen análisis que relacionen estos microorganismos con niños. Por otra parte, las bacterias cariogénicas deben presentan mecanismos de patogenicidad para producir la enfermedad, entre los que se han descrito la aciduria, acidogénesis y la adhesión, todas codificadas por genes. En el presente estudio se buscará la presencia de estos mecanismos a partir de los genes ldh, gadB y spaA. OBJETIVO: Determinar la presencia de miembros de la familia Bifidobacteriaceae en saliva y caries de niños Chilenos entre 7 y 11 años de edad y analizar los genes que codifican para los factores de virulencia ldh, gadB y spaA. METODOLOGÍA: Mediante examen clínico, se seleccionó un grupo de 18 niños, 9 niños sin experiencia de caries y 9 con experiencia de caries. Se tomaron muestras de saliva de ambos grupos y muestras de sitio con caries en dentina a niños con experiencia de caries. Se procedió a realizar cultivos en medio MTPY, selectivo para Bifidobacteriaceae. Se aisló ADN genómico desde aislados clínicos seleccionados al azar, se realizó PCR para amplificar un fragmento del ADN del gen 16S ARNr y fueron enviados para su secuenciación. El análisis de estas secuencias permitió identificar las especies presentes en cada muestra. La presencia de los factores de virulencia se realizó por PCR, utilizando partidores específicos para cada gen en análisis (ldh, gadB y spaA). RESULTADOS: Se detectó Parascardovia denticolens, miembro de la familia Bifidobacteriaceae, en el 5,6% de los niños estudiados (n=18). Mediante PCR se determinó que de los aislados clínicos obtenidos, el 50% dió positivo para el factor de virulencia ldh mientras que para los factores de virulencia gadB y spaA no fue posible obtener un amplificado positivo. No se obtuvieron aislados clínicos para otras especies de Bifidobacteriaceae. La especie Actinomyces odontolyticus fue encontrada abundantemente en muestras de saliva del grupo de niños con experiencia de caries y sin experiencia de caries. Se determinó una asociación estadísticamente significativa de este microorganismo a las muestras de saliva de ambos grupos, al comparar con su presencia en los sitios con caries (p=0,01 y p=0,001). Rothia mucilaginosa se encontró asociada a las muestras de saliva en ausencia de experiencia de caries al comparar con su presencia en sitios con caries (p=0,001). CONCLUSIONES: En niños Chilenos entre 7 y 11 años sólo fue posible detectar la presencia de P. denticolens desde sitios con caries, única especie de los siete géneros de la familia Bifidobacteriaceae. Los aislados clínicos de P. denticolens codifican el gen Idh en un 50% de los aislados, mientras que no codifican para los genes spaA y gadB, por lo que estos aislados no usarían estos mecanismos descritos para la adhesión y resistencia de ambientes ácidos. Se encontraron otras especies bacterianas asociadas al tipo de muestra, como A. odontolyticus encontrada en saliva tanto de niños libres de caries como con experiencia de caries. De este mismo modo existen especies bacterianas relacionadas a la ausencia de caries, como R. mucilaginosa.
Adscrito a Proyecto U-inicia difarp 40/13, VID, U. de Chile
Adhikari, Koushik. "Viability and metabolic activity of encapsulated bifidobacteria in yogurt /." free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9999266.
Full textCho, Young-Jae. "Investigation of the functionality of probiotic fortified soy beverages : in vitro and and in vivo studies /." free to MU campus, to others for purchase, 2004. http://wwwlib.umi.com/cr/mo/fullcit?p3144409.
Full textMeyer, Catherine. "Les bifidobacteries : proprietes, role nutritionnel, applications dietetiques." Strasbourg 1, 1992. http://www.theses.fr/1992STR15019.
Full textHung, Ming-Ni 1962. "Biochemical and genomic analysis of -galactosidases from Bifidobacterium infantis HL96." Thesis, McGill University, 2001. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=36953.
Full textTwo genes, beta-galI and beta-galIII, located on 4.6 and 4.4 kb DNA fragments respectively, were cloned into E. coli, and the nucleotide sequences were determined. The 3,069 by-long beta-galI, encoded a polypeptide with a Mr of 113 kDa. A putative ribosome-binding site and a promoter sequence were recognized at the 5' flanking region of beta-galI. A partial sequence of an ORF transcribing divergently from beta-galI resembled a lactose permease gene. The beta-galIII gene, which is 2,076 bp long, encoded a polypeptide with a Mr of 76 kDa. A rho-independent, transcription terminator-like sequence was found 25 bp downstream of the termination codon.
The amino acid sequences of beta-GalI and beta-GalIII were homologous to those in the LacZ and LacG families, respectively. The acid-base, nucleophilic, and substrate recognition sites conserved in the LacZ family were found in beta-GalI, and a possible acid-base site proposed for the LacG family was located in beta-GalIII, containing a glutamate at residue 160. beta-GalI and beta-GalIII were over-expressed 35 and 96 times respectively in E. coli by using a pET expression system.
Both beta-GalI and beta-GalIII were specific for beta-D -anomeric linked galactosides, but beta-GalI showed more hydrolytic and synthetic activities toward lactose than beta-GalIII. The galacto-oligosaccharides (GaOS) production mediated by beta-GalI at 37°C in 20% (w/v) lactose was 130 mg/ml, which is six times higher than that of beta-GalIII. The yield of GaOS further increased to 190 mg/ml in 30% (w/v) lactose. A major tri-saccharide produced by beta-GalI was characterized as O-beta- D-galactopyranosyl-(1-3)-O-beta-D-galactopyranosyl-(1-4)- D-glucopyranose.
beta-GalI was purified by ammonium sulphate precipitation, and anion-exchange (Mono-Q) and gel filtration (Superose 12) chromatographic steps. The enzyme appeared to be a tetramer, with a Mr of 470 kDa as estimated by native PAGE and gel-filtration chromatography. The optimum temperature and pH for ONPG and lactose as substrates were 60°C, pH 7.5, and 50°C, pH 7.5, respectively. The enzyme was stable over the pH range of 5~8.5, and was particularly active at 50°C for more than 80 min. The enzyme was significantly activated by reducing agents, especially glutathione, as well as by Na+ and K+ cations. Maximal activity required both Na+ and K+ at a concentration of 10 mM. The enzyme was strongly inhibited by p-chloromercuribenzoic acid, and by most bivalent metal ions. Hydrolytic activity using 20 mM lactose as substrate was significantly inhibited by 10 mM galactose. The Km and Vmax values for ONPG and lactose were 2.6 mM, 262 U/mg, and 73.8 mM, 1.28 U/mg, respectively.
The objectives of this research were to characterize beta-galactosidases of B. infantis HL96 at the molecular and biochemical levels, and to over-express the enzymes in Escherichia coli. Two beta-galactosidase isoenzymes with unique properties were genetically characterized for the first time. beta-GalI properties included a neutral pH optimum, relatively higher temperature stability and a high transgalactosylic activity that makes it very competitive for GaOS synthesis. The results were also important for the advancement of knowledge on the catalytic mechanism and the evolutionary aspect of this enzyme.
Krzewinski, Frédéric. "Transport et métabolisme des saccharides chez Bifidobacterium bifidum SM 20082." Lille 1, 1997. http://www.theses.fr/1997LIL10005.
Full textЛиповська, Вікторія Вікторівна, Виктория Викторовна Липовская, Viktoriia Viktorivna Lypovska, and К. Ю. Ковальчук. "Зміни вмісту Bifidobacterium bifidum у хворих на шигельоз та сальмонельоз." Thesis, Видавництво СумДУ, 2009. http://essuir.sumdu.edu.ua/handle/123456789/4716.
Full textTu, Liwen. "Cloning and sequence analysis of multiple genes from Bifidobacterium infantis /." free to MU campus, to others for purchase, 2004. http://wwwlib.umi.com/cr/mo/fullcit?p3137758.
Full textTacconi, Stefano <1961>. "Rapporti fra fattori ambientali e proteine di parete in Bifidobacterium." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2009. http://amsdottorato.unibo.it/2041/1/tacconi_stefano_tesi.pdf.
Full textTacconi, Stefano <1961>. "Rapporti fra fattori ambientali e proteine di parete in Bifidobacterium." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2009. http://amsdottorato.unibo.it/2041/.
Full textSatti, Maria Altaf <1991>. "Comparative Analysis of Genus Bifidobacterium: Insight into its Host Adaptation." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2021. http://amsdottorato.unibo.it/9892/1/Doctoral%20Thesis.pdf.
Full textMartin, Laurence. "Modulation des propriétés des cellules dendritiques humaines par un surnageant de bactérie probiotique : induction de lymphocytes T régulateur." Thesis, Tours, 2008. http://www.theses.fr/2008TOUR3107.
Full textThe immune system protects our organism by removing pathogen bacteria and viruses while tolerating non-pathogenic antigens from self, environment and commensal bacteria. Some commensal bacteria called “probiotics” have been shown to exert beneficial effects on the host health. Recent studies demonstrated that these probiotic bacteria could act on immune cells either directly or via their metabolites. Dendritic cells (DC) are able to induce either an effective or a tolerogenic immune response depending on the environment signals. They can be found in the intestinal mucosa where they could interact with probiotic bacteria. We demonstrated that a bacteria-free fermentation product of Bifidobacterium breve C50 (BbC50sn) induced human DC maturation with high IL-10 production in vitro and prolonged their survival. The BbC50sn action on dendritic cells was mediated via the TLR-2 pathway. The DNA microarray analysis showed that BbC50sn-DC produced high levels of mRNA corresponding to genes encoding tolerogenic molecules such as ILT-3, ILT-4 and PDL-1. We also highlighted that these BbC50sn-DC could induce functional regulatory T cells in vitro. These regulatory T cells needed an alloantigen specific activation to exert their suppressive activity and didn’t act through a T cell-T cell contact. These regulatory T cells secreted IL-10 and TGF-ß; however, these cytokines didn’t appear to mediate the suppressive activity. We also showed that other dendritic cells treated with TLR-2 and TLR-4 ligands could induce regulatory T cells different from those induced by BbC50sn-DC. BbC50sn is thus able to exert a regulatory effect through this action on human dendritic cells by inducing regulatory T cells in vitro. As far as we know, it is the first demonstration of regulatory T cell induction by a probiotic derivative product. These results represent a rational basis for BbC50sn use in clinics
Kim, Geun-Bae 1966. "Biochemical and genomic analysis of bile salt hydrolases from Bifidobacterium strains." Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=84272.
Full textAs the type A bsh gene was cloned from a strain of B. longum and the nucleotide sequence became available from the GenBank, our study has focused on the cloning and characterization of the type B and C bsh genes from Bifidobacterium strains.
The type B bsh gene was cloned from B. bifidum ATCC11863 and the DNA flanking the bsh gene was sequenced. The 951 by-long bsh gene encoded a 316-amino-acid protein with a molecular mass of 35 kDa and a pI of 4.48. For the first time in the genus Bifidobacterium, the transcriptional start point of the bsh gene was identified by primer extension analysis. Furthermore, Northern blot analysis revealed that B. bifidum bsh was transcribed as a monocistronic unit, contrary to that of B. longum bsh. Despite a high level of sequence similarity among the bsh genes, a BSH type-specific primer set based on the variable regions of bsh genes was designed in order to differentiate B. bifidum strains from the other species of Bifidobacterium commonly detected in the human gut.
The type C bsh gene was cloned from a bile salt tolerant strain of Bifidobacterium and the DNA flanking the bsh gene was further identified by a thermal asymmetric interlaced PCR (TAIL-PCR) technique. The 945 by-long bsh gene encoded a 314-amino-acid protein with a molecular mass of 35 kDa and a pI of 4.71. A predicted BSH promoter (Pbsh) sequence was experimentally verified and the transcriptional start point of the type C bsh gene was determined by primer extension analysis. An operonic structure including the type C bsh gene and two more ORFs, which were found within a complete set of a promoter and a transcription terminator, was identified in this study for the first time in the genus Bifidobacterium, and the polycistronic bsh transcript was revealed by RT-PCR and Northern blot analysis.
Savard, Patricia. "L'expression des gènes responsables du catabolisme de l'arabinoxylane chez Bifidobacterium longum." Thesis, Université Laval, 2007. http://www.theses.ulaval.ca/2007/24549/24549.pdf.
Full textAudy, Julie. "Approche transcriptionnelle pour l'étude de gènes chez Bifidobacterium longum CRC 002." Thesis, Université Laval, 2008. http://www.theses.ulaval.ca/2008/25448/25448.pdf.
Full textBull, Matthew J. "Molecular genetic characterisation of probiotic bacteria : Lactobacillus acidophilus and Bifidobacterium species." Thesis, Cardiff University, 2013. http://orca.cf.ac.uk/53985/.
Full textMartinez, Fabio Andres Castillo. "Produção de bacteriocina por Bifidobacterium lactis a partir de leite desnatado." Universidade de São Paulo, 2013. http://www.teses.usp.br/teses/disponiveis/9/9135/tde-16012014-134005/.
Full textThere are few publications that have been reported about bacteriocin production by Bifidobacterium species. Therefore, the aim of this work was measure bacteriocin production in skim milk by B. lactis. Consequently, this work was divided in three stages. First, MRS, BSM and LD medium were tested with additives (Tween 80 (T80), Inuline (I) or Yeast extract (YE)) for bacteriocin production and cellular growth. Fermentation processes were conducted in shaker under specific conditions: 50 rpm/37ºC/48h. pH; sugars; acids; biomass, and bacteriocin activity against L. monocytogenes, L. plantarum, E. coli, L. sakei e S. aureus strains were analyzed . In the second stage, based on the obtained results, a central composite design (CCD) was created using the parameters: temperature (34, 37, 40 ºC), and concentration of YE (0.5, 1.0, 1.5 g/L). After, the activity was measured by two methods of plates pre-diffusion (cooling and addition of Tween 20). Third step consisted of 2 L bioreactor cultivations containing 10% skim milk diluted in 1.5 L of water (6.5 pH), under 200 rpm, 36 ºC, 2.0 g/L of YE, 48h, under anaerobic condition. Finally, the cultures supplemented with LD and YE (1%) with a modified plate diffusion method (cooling plates for 12 h) showed bacteriocin activity against L. monocytogenes (2130 AU/mL) with an exponential phase of 24 h, µm of 0.604/h. The optimization performed using CCD resulted in a higher level of activity 3000 AU/mL to 3100 AU/mL mL (Run 7, 11 and 14, blocks 3 and 1) against L. monocytogenes, also with ideal growth conditions of YE: 2,0 g/L1 and T °C: 36 °C. The pH value varied between 6.4 and 4.0. Concentration of produced acid lactic varied from 3.03 to 4.72 g/L and biomass concentration from 3.4 to 11.1 Lg UFC/mL. Regression analysis was significant to the variables: YE concentration and temperature. Results indicated that skim milk is a proper medium for \"Bifidobacteriocin\" production.
Stenico, Verena <1983>. "Genus Bifidobacterium: taxonomy studies and gene expression analysis on folate pathway." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2014. http://amsdottorato.unibo.it/6604/1/Stenico_Verena_tesi.pdf.
Full textStenico, Verena <1983>. "Genus Bifidobacterium: taxonomy studies and gene expression analysis on folate pathway." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2014. http://amsdottorato.unibo.it/6604/.
Full textSouza, Cínthia Hoch Batista de. "Desenvolvimento de margarina probiótica e simbiótica: viabilidade do probiótico no produto e resistência in vitro." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/9/9133/tde-17112010-174506/.
Full textThis study aimed to determine the viability of probiotic Bifidobacterium animalis subsp. lactis Bb-12 incorporated in margarine, with inulin, whey protein concentrate (WPC) and caseinomacropeptide (CMP) supplementation. In addition, the in vitro resistance of Bb-12 incorporated in margarine and related properties were evaluated. Seven margarine-making trials (60% of fat: 60% of palm oil +40% canola oil) were produced, using a mixture model, where inulin, WPC and CMP were the variables studied. Also, a control formulation without these ingredients was manufactured. The use of blending palm oil with canola oil improved the margarine formulations nutritionally, providing products containing essential fatty acids in its composition and absence of trans fatty acids. The formulations M1 to M7, except M2 after 21 days of storage, revealed satisfactory Bb-12 populations for a probiotic food, with counts above 6 log CFU/g during 35 days of storage at 5±1ºC. Margarines supplemented with inulin presented suitable Bb-12 populations throughout the whole storage period, reaching up to 8 log CFU/g by the end of storage (M1). Also, M3 and M6, revealed Bb-12 populations of 6.87 log CFU/g and of 7.27 log CFU/g (day 35), respectively. In contrast, M8 was not characterized as probiotic margarine, since it showed Bb-12 populations below 6 log CFU/g on day 1. Even though whey protein is largely employed in probiotic foods, margarine supplementation with WPC without inulin or CMP did not lead to Bb-12 satisfactory populations, decreasing from 7.82 (day 1) to 4.64 log CFU/g (M2, day 35) (p<0.05). During the whole in vitro assays, Bb-12 survived significantly better (p<0.05) in M1 and revealed populations above 6 log CFU/g after 6h even after 28 days. M2 populations decreased drastically during the in vitro assays for all storage period tested (reduction of 5 log CFU/g after 2h of in vitro assays on day 7 and populations of 2.8 log CFU/g after 6h). For the other formulations, Bb-12 populations decreased 2 log CFU/g after 2h of the in vitro assays. However, for M1, M2 and M5 (on day 14 and 28) the populations of Bb-12 increased significantly (p<0.05) between the gastric phase (2h) and the enteric phase (6h). Formulations containing inulin, mainly M1, showed a significant decrease in pH values during the whole storage period (p<0.05). However, this ingredient did not affect the sensory quality of products, since no significant differences between formulations after 7 and 14 days of storage were observed (p>0.05). The supplementation of margarine with inulin and CMP guaranteed appropriate Bb-12 populations during storage for at least 28 days, and also contributed for its survival throughout the in vitro assays. Therefore, margarine might be considered an appropriate food matrix for Bb-12 survival, mainly when inulin is also added.
Inturri, Rosanna. "Caratterizzazione microbiologica di ceppi di Bifidobacterium spp. e analisi chimica e biologica di un esopolisaccaride prodotto." Doctoral thesis, Università di Catania, 2016. http://hdl.handle.net/10761/3921.
Full textGorse, Christophe. "Etude expérimentale des translocations bactériennes lors d'aplasies médullaires : rôle de Saccharomyces boulardii et de Bifidobacterium." Montpellier 1, 1992. http://www.theses.fr/1992MON11037.
Full textMullié-Demailly, Catherine. "Contribution a l'etude de l'innocuite et de la specificite d'action de bifidobacterium breve c50 et de ses produits de fermentation (doctorat : microbiologie)." Lille 2, 1999. http://www.theses.fr/1999LIL2P253.
Full textKhattabi, Abdelkrim. "Contribution a la classification et a l'ecologie de souches d'origine humaine appartenant au genre bifidobacterium : mise au point d'un systeme d'identification numerique." Lille 2, 1993. http://www.theses.fr/1993LIL2P253.
Full textRavenscroft, John Elmer. "Evaluation of survival and recovery characteristics of bifidobacteria as indicators of fecal pollution of water." Morgantown, W. Va. : [West Virginia University Libraries], 2000. http://etd.wvu.edu/templates/showETD.cfm?recnum=1613.
Full textTitle from document title page. Document formatted into pages; contains xi, 138 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references (p. 133-137).